We’ll update again in the spring with more info on additional testing. January 2025 Like love itself, flowers are precious and unique. And that is exactly why it’s so tricky to get both right.

Emily in Pars star Lily Collins and Charlie McDowell have welcomed their first child, a baby girl named Tove Jane McDowell, via surrogate, the actress announced on Friday. The Emily in Paris star, 35, ...

The more time you spend around the devil’s tongue, the more its smell gets under your skin. It first greets you as a dull odor, somewhat akin to a wet dog or raw fish. But stick around long ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Eli Lilly recently updated Q4 revenue guidance, and sales are expected to come in lower than previously anticipated. While this could suggest the company is experiencing sluggish or plateauing ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December scripts boost. The stock is attractively valued at current levels.

The Santa Barbara Film Festival has revealed its entire program for its upcoming 40th edition, which includes 32 world premieres and 74 U.S. premieres from 60 countries. The fest will open ...

the flower girl tells PEOPLE Hannah Tingle/MHT Media A bride and groom had an untraditional wedding processional. Blake and Cassie Conley got married in an intimate wedding ceremony on Dec. 17 ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...